Product and Claim Development
Compelling claims to capture the minds of consumers
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgique
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Public Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSFEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions with Apple devices
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Public Health
- Code of Conduct
- Sustainability
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions with Apple devices
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREWORKING AT IQVIA
Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORELIFE AT IQVIA
Careers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
WE’RE HIRING
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSBlog
$name
May 20, 2020
Exhibit 1: Consumer health categories that have a potential relevance in the course of the COVID-19 crisis
If we take a snapshot of seven European countries - France, Germany, Italy, Spain, Czech Republic, Hungary and Poland - looking at pharmacy value sales (millions of packs) for the 14 weeks ending 5 April 2020, we see that as the pandemic in Europe truly took hold in Italy at around week 8, preventative products such as hand gels and sanitizers begin to rise and peak a week later in week 9 as people rushed to source hand sanitizers and gels from wherever they could (see Exhibit 2).
If we take a snapshot of seven European countries - France, Germany, Italy, Spain, Czech Republic, Hungary and Poland - looking at pharmacy value sales (millions of packs) for the 14 weeks ending 5 April 2020, we see that as the pandemic in Europe truly took hold in Italy at around week 8, preventative products such as hand gels and sanitizers begin to rise and peak a week later in week 9 as people rushed to source hand sanitizers and gels from wherever they could (see Exhibit 2).
Exhibit 2: As COVID-19 hits Europe, sales of OTC remedies in CCR, Pain and VMS+Tonics, as well as Hand Hygiene products start to rise from week 8. (Source: IQVIA CH Weekly Sales (Sell-out) *European Countries: France, Germany, Italy, Spain, Czech Republic, Hungary, Poland)
At the same time, sales in the cough and cold, pain and vitamins, minerals and supplements (VMS) categories also started to rise. However, the peak in sales is later - between weeks 11 and 12, as people prepared for lockdown and started to stock up on essential symptom-relief products, such as general pain relief to help with fever, cough and cold remedies, as well as products like multivitamins and vitamin C to maintain good health and boost the immune system.
When we look at the broader consumer health market across all segments of OTC, personal care, nutrition and patient care, we see a similar picture of a sharp peak in sales during weeks 8 to 12 as the pandemic spread and consumers/shoppers started stocking up on essential products in preparation for lockdown.
Outside of these categories, there will be other products within the consumer health segment that also experienced similar spikes in consumer demand, although these will vary by country, including: special adult nutrition/ baby food/formula milks within the nutrition segment; masks/gloves/thermometers and essential regular use products where people are likely to be stocking up, such as incontinence care products in the patient care category; and hair care in personal care.
The rapid sales rises that began around week 8 are reflected in the social media conversations analyzed using our IQVIA social intelligence solutions and real-time analysis, as conversations turned toward concern around a lack of availability in stores and higher prices of essential products as lockdown measures came into place a few weeks later (see Exhibit 3).
At the same time, sales in the cough and cold, pain and vitamins, minerals and supplements (VMS) categories also started to rise. However, the peak in sales is later - between weeks 11 and 12, as people prepared for lockdown and started to stock up on essential symptom-relief products, such as general pain relief to help with fever, cough and cold remedies, as well as products like multivitamins and vitamin C to maintain good health and boost the immune system.
When we look at the broader consumer health market across all segments of OTC, personal care, nutrition and patient care, we see a similar picture of a sharp peak in sales during weeks 8 to 12 as the pandemic spread and consumers/shoppers started stocking up on essential products in preparation for lockdown.
Outside of these categories, there will be other products within the consumer health segment that also experienced similar spikes in consumer demand, although these will vary by country, including: special adult nutrition/ baby food/formula milks within the nutrition segment; masks/gloves/thermometers and essential regular use products where people are likely to be stocking up, such as incontinence care products in the patient care category; and hair care in personal care.
The rapid sales rises that began around week 8 are reflected in the social media conversations analyzed using our IQVIA social intelligence solutions and real-time analysis, as conversations turned toward concern around a lack of availability in stores and higher prices of essential products as lockdown measures came into place a few weeks later (see Exhibit 3).
Exhibit 3: Examples of COVD-19 related conversations involving consumer health products. (Source: IQVIA Social Media Listening *Includes twitter, news and forums. Facebook is not included *includes products from CCR, VMS and Pain management categories)
Media coverage of certain issues - such as when it was suggested that ibuprofen could be a factor in aggravating the infection - may also have contributed to spikes in both conversation subject matter online and sales increases.
Finally, some observations on consumer healthcare product sales through on-line pharmacies vs off-line pharmacies in the first quarter of 2020 compared to the same period last year. It is important to note that in some of these markets, on-line or mail order pharmacies may already be a mature and established channel, such as in Germany. And in other markets, the share of on-line pharmacy may still be relatively small, such as in Poland.
However, across all countries, we clearly see growth rate for consumer healthcare products through on-line pharmacies exceeded those of retail pharmacies in Q1 versus the same period last year. In countries like Hungary and the Czech Republic, online sales are 4x bigger than offline, while in Italy, on-line is 13x times bigger (see Exhibit 4).
Exhibit 4: Total CH Market Growth (%) Q1 2020 vs same period last year - off-line vs on-line value sales (Source: IQVIA)
As most countries go into lockdown, with restrictions on movements as well as diminishing supplies, people are clearly looking to buy more through the on-line channels during this crisis period. And it will be interesting to monitor how this will further develop in the future.
For further information on how COVID-19 is impacting consumer health contact: consumer.health@iqvia.com
As most countries go into lockdown, with restrictions on movements as well as diminishing supplies, people are clearly looking to buy more through the on-line channels during this crisis period. And it will be interesting to monitor how this will further develop in the future.
For further information on how COVID-19 is impacting consumer health contact: consumer.health@iqvia.com
Related solutions
Concept and Strategy Development
Illuminate a path to consumer health success
Consumer Health
Shape the future of consumer health.
Industry Segments
See how we partner with organizations across the healthcare ecosystem, from emerging biotechnology and large pharmaceutical, to medical technology, consumer health, and more, to drive human health forward.